Skin permeation, biodistribution, and expression of topically applied plasmid DNA

Min Jeong Kang, Chong Kook Kim, Mi Young Kim, Tae Sun Hwang, Sang Yoon Kang, Won-Ki Kim, Jung Jae Ko, Yu Kyoung Oh

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Background. Topical application is emerging as a new route of gene delivery. However, the extent of skin permeation and the in vivo fate of topically applied plasmid DNA are not fully understood. Methods. In vitro permeation of plasmid DNA across human skin and keratinocyte layers was tested using Franz diffusion cells. In vivo absorption and biodistribution of topically applied plasmid in mice were determined using quantitative polymerase chain reaction (PCR). The expression levels of plasmid DNA in various tissues were measured by semiquantitative reverse transcription PCR. Results. In vitro, topically applied DNA was capable of penetrating human skin and keratinocyte layers. Following topical application of plasmid DNA onto murine skin, the levels of plasmid DNA in the serum peaked at 4 hr. At 24 hr post-dose, topically applied DNA existed at higher levels than intravenously administered DNA in almost all tissues, and induced 11.4- and 22-fold higher mRNA expression in muscle and skin, respectively. Moreover, the topical route showed sustained expression of plasmid DNA in the regional lymph nodes over 5 days, whereas the intravenous route did not. Conclusions. Taken together, our results show that topically applied plasmid DNA is capable of permeating the skin and being expressed for prolonged periods in various tissues including lymph nodes. This suggests that skin may provide an appealing, noninvasive route of delivery for DNA vaccines and other therapeutic genes.

Original languageEnglish
Pages (from-to)1238-1246
Number of pages9
JournalJournal of Gene Medicine
Volume6
Issue number11
DOIs
Publication statusPublished - 2004 Nov 1
Externally publishedYes

Fingerprint

Plasmids
Skin
DNA
Keratinocytes
Lymph Nodes
Polymerase Chain Reaction
DNA Vaccines
Genes
Reverse Transcription
Muscles
Messenger RNA
Serum

Keywords

  • Expression
  • Lymph nodes
  • Permeation
  • Plasmid DNA
  • Topical application

ASJC Scopus subject areas

  • Genetics

Cite this

Kang, M. J., Kim, C. K., Kim, M. Y., Hwang, T. S., Kang, S. Y., Kim, W-K., ... Oh, Y. K. (2004). Skin permeation, biodistribution, and expression of topically applied plasmid DNA. Journal of Gene Medicine, 6(11), 1238-1246. https://doi.org/10.1002/jgm.620

Skin permeation, biodistribution, and expression of topically applied plasmid DNA. / Kang, Min Jeong; Kim, Chong Kook; Kim, Mi Young; Hwang, Tae Sun; Kang, Sang Yoon; Kim, Won-Ki; Ko, Jung Jae; Oh, Yu Kyoung.

In: Journal of Gene Medicine, Vol. 6, No. 11, 01.11.2004, p. 1238-1246.

Research output: Contribution to journalArticle

Kang, MJ, Kim, CK, Kim, MY, Hwang, TS, Kang, SY, Kim, W-K, Ko, JJ & Oh, YK 2004, 'Skin permeation, biodistribution, and expression of topically applied plasmid DNA', Journal of Gene Medicine, vol. 6, no. 11, pp. 1238-1246. https://doi.org/10.1002/jgm.620
Kang, Min Jeong ; Kim, Chong Kook ; Kim, Mi Young ; Hwang, Tae Sun ; Kang, Sang Yoon ; Kim, Won-Ki ; Ko, Jung Jae ; Oh, Yu Kyoung. / Skin permeation, biodistribution, and expression of topically applied plasmid DNA. In: Journal of Gene Medicine. 2004 ; Vol. 6, No. 11. pp. 1238-1246.
@article{b438fd002f4a45318133188b19a87adf,
title = "Skin permeation, biodistribution, and expression of topically applied plasmid DNA",
abstract = "Background. Topical application is emerging as a new route of gene delivery. However, the extent of skin permeation and the in vivo fate of topically applied plasmid DNA are not fully understood. Methods. In vitro permeation of plasmid DNA across human skin and keratinocyte layers was tested using Franz diffusion cells. In vivo absorption and biodistribution of topically applied plasmid in mice were determined using quantitative polymerase chain reaction (PCR). The expression levels of plasmid DNA in various tissues were measured by semiquantitative reverse transcription PCR. Results. In vitro, topically applied DNA was capable of penetrating human skin and keratinocyte layers. Following topical application of plasmid DNA onto murine skin, the levels of plasmid DNA in the serum peaked at 4 hr. At 24 hr post-dose, topically applied DNA existed at higher levels than intravenously administered DNA in almost all tissues, and induced 11.4- and 22-fold higher mRNA expression in muscle and skin, respectively. Moreover, the topical route showed sustained expression of plasmid DNA in the regional lymph nodes over 5 days, whereas the intravenous route did not. Conclusions. Taken together, our results show that topically applied plasmid DNA is capable of permeating the skin and being expressed for prolonged periods in various tissues including lymph nodes. This suggests that skin may provide an appealing, noninvasive route of delivery for DNA vaccines and other therapeutic genes.",
keywords = "Expression, Lymph nodes, Permeation, Plasmid DNA, Topical application",
author = "Kang, {Min Jeong} and Kim, {Chong Kook} and Kim, {Mi Young} and Hwang, {Tae Sun} and Kang, {Sang Yoon} and Won-Ki Kim and Ko, {Jung Jae} and Oh, {Yu Kyoung}",
year = "2004",
month = "11",
day = "1",
doi = "10.1002/jgm.620",
language = "English",
volume = "6",
pages = "1238--1246",
journal = "Journal of Gene Medicine",
issn = "1099-498X",
publisher = "John Wiley and Sons Ltd",
number = "11",

}

TY - JOUR

T1 - Skin permeation, biodistribution, and expression of topically applied plasmid DNA

AU - Kang, Min Jeong

AU - Kim, Chong Kook

AU - Kim, Mi Young

AU - Hwang, Tae Sun

AU - Kang, Sang Yoon

AU - Kim, Won-Ki

AU - Ko, Jung Jae

AU - Oh, Yu Kyoung

PY - 2004/11/1

Y1 - 2004/11/1

N2 - Background. Topical application is emerging as a new route of gene delivery. However, the extent of skin permeation and the in vivo fate of topically applied plasmid DNA are not fully understood. Methods. In vitro permeation of plasmid DNA across human skin and keratinocyte layers was tested using Franz diffusion cells. In vivo absorption and biodistribution of topically applied plasmid in mice were determined using quantitative polymerase chain reaction (PCR). The expression levels of plasmid DNA in various tissues were measured by semiquantitative reverse transcription PCR. Results. In vitro, topically applied DNA was capable of penetrating human skin and keratinocyte layers. Following topical application of plasmid DNA onto murine skin, the levels of plasmid DNA in the serum peaked at 4 hr. At 24 hr post-dose, topically applied DNA existed at higher levels than intravenously administered DNA in almost all tissues, and induced 11.4- and 22-fold higher mRNA expression in muscle and skin, respectively. Moreover, the topical route showed sustained expression of plasmid DNA in the regional lymph nodes over 5 days, whereas the intravenous route did not. Conclusions. Taken together, our results show that topically applied plasmid DNA is capable of permeating the skin and being expressed for prolonged periods in various tissues including lymph nodes. This suggests that skin may provide an appealing, noninvasive route of delivery for DNA vaccines and other therapeutic genes.

AB - Background. Topical application is emerging as a new route of gene delivery. However, the extent of skin permeation and the in vivo fate of topically applied plasmid DNA are not fully understood. Methods. In vitro permeation of plasmid DNA across human skin and keratinocyte layers was tested using Franz diffusion cells. In vivo absorption and biodistribution of topically applied plasmid in mice were determined using quantitative polymerase chain reaction (PCR). The expression levels of plasmid DNA in various tissues were measured by semiquantitative reverse transcription PCR. Results. In vitro, topically applied DNA was capable of penetrating human skin and keratinocyte layers. Following topical application of plasmid DNA onto murine skin, the levels of plasmid DNA in the serum peaked at 4 hr. At 24 hr post-dose, topically applied DNA existed at higher levels than intravenously administered DNA in almost all tissues, and induced 11.4- and 22-fold higher mRNA expression in muscle and skin, respectively. Moreover, the topical route showed sustained expression of plasmid DNA in the regional lymph nodes over 5 days, whereas the intravenous route did not. Conclusions. Taken together, our results show that topically applied plasmid DNA is capable of permeating the skin and being expressed for prolonged periods in various tissues including lymph nodes. This suggests that skin may provide an appealing, noninvasive route of delivery for DNA vaccines and other therapeutic genes.

KW - Expression

KW - Lymph nodes

KW - Permeation

KW - Plasmid DNA

KW - Topical application

UR - http://www.scopus.com/inward/record.url?scp=13644257864&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13644257864&partnerID=8YFLogxK

U2 - 10.1002/jgm.620

DO - 10.1002/jgm.620

M3 - Article

C2 - 15459965

AN - SCOPUS:13644257864

VL - 6

SP - 1238

EP - 1246

JO - Journal of Gene Medicine

JF - Journal of Gene Medicine

SN - 1099-498X

IS - 11

ER -